Go to deals
Private Equity | Healthcare

Anbioton has been acquired by Elfa Medicamentos

The shareholders of Anbioton have sold the company to Elfa Medicamentos, a Patria Investimentos portfolio company.

Anbioton is focused on the Brazilian pharmaceutical distribution market. The company serves close to 1,400 private hospitals and 200 public entities through partnership agreements with more than 75 pharmaceutical companies.

Elfa Medicamentos was founded in 1989 by Edalmo Leite Fernandes Assis. The company’s operations are focused on the distribution of specialty medicines and generic and branded drugs, hospital supplies, and high value-added solutions for medical plans, clinics, hospitals, government, doctors and patients across the country.

One of Oaklins’ teams in Brazil acted as the exclusive sell-side advisor for Anbioton and its shareholders.

Service
M&A sell-side
Parties

Talk to the deal team

 Irajá  Guimarães

Irajá Guimarães

Partner
São Paulo, Brazil
Oaklins Olimpia Partners
 Victor  Andreoli

Victor Andreoli

Partner
São Paulo, Brazil
Oaklins Olimpia Partners
 Thomas  Monteiro

Thomas Monteiro

Partner
São Paulo, Brazil
Oaklins Olimpia Partners

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Ricotto has been acquired by Sitra Group
Private Equity | Logistics

Ricotto has been acquired by Sitra Group

Ricotto S.r.l. has joint Sitra Group, a Belgium-based and PE-backed international logistic and transportation group.

Learn more
M80 Partners has acquired Luminis
Private Equity | TMT

M80 Partners has acquired Luminis

Belgian private equity fund M80 has acquired a majority stake in Luminis. M80 offers to software and technology company Luminis the opportunity to further expand its strategy and market position internationally. Luminis becomes part of a platform that also includes XPLUS, a Belgian expert in enterprise IT architecture. M80 plans to make further selective acquisitions in Europe in the coming months with the aim of bringing together a portfolio of best-in-class digital transformation specialists.

Learn more